acitretin has been researched along with Hypertriglyceridemia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Armour, K; Chan, BC; George, PM; Maurice, PD; Reid, N; Scott, RS | 1 |
| Lipsker, D; Lutz, V | 1 |
| Allen, MH; Barker, JN; Burden, AD; Campalani, E; Crook, MA; Fairhurst, D; Griffiths, CE; Mendonca, CO; Smith, CH; Young, HS | 1 |
3 other study(ies) available for acitretin and Hypertriglyceridemia
| Article | Year |
|---|---|
Hypertriglyceridaemia with acitretin use: a proposal for its management in the context of overall cardiovascular risk.
Topics: Acitretin; Cardiovascular Diseases; Humans; Hypertriglyceridemia; Keratolytic Agents; Psoriasis; Retrospective Studies; Risk Assessment; Risk Reduction Behavior | 2014 |
Acitretin- and tumor necrosis factor inhibitor-resistant acrodermatitis continua of hallopeau responsive to the interleukin 1 receptor antagonist anakinra.
Topics: Acitretin; Acrodermatitis; Antirheumatic Agents; Drug Administration Schedule; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Fenofibrate; Humans; Hypertriglyceridemia; Injections, Subcutaneous; Interleukin 1 Receptor Antagonist Protein; Keratolytic Agents; Middle Aged; Psoriasis; Receptors, Interleukin-1; Recombinant Proteins; Recurrence; Triglycerides; Tumor Necrosis Factor-alpha | 2012 |
Apolipoprotein E gene polymorphisms are associated with psoriasis but do not determine disease response to acitretin.
Topics: Acitretin; Adolescent; Adult; Aged; Aged, 80 and over; Apolipoprotein E4; Apolipoproteins E; Child; Female; Genetic Markers; Genetic Predisposition to Disease; Genotype; Humans; Hypertriglyceridemia; Keratolytic Agents; Male; Middle Aged; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Psoriasis; Sequence Analysis, DNA; Treatment Outcome | 2006 |